Home Clinical Topics FDA approves new type of drug for insomnia

FDA approves new type of drug for insomnia

On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor antagonist. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here